Status:
COMPLETED
Cryoballoon PVI With PWI Versus PVI Alone In Patients With PAF
Lead Sponsor:
Sacramento EP Research
Collaborating Sponsors:
Mercy General Hospital and Dignity Health Heart and Vascular Institute
UC Health Medical Center
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Cryoballoon ablation has emerged as a safe and effective strategy for treatment of atrial fibrillation (AF) for which it has recently received a 'first-line' therapy indication by the FDA. Pulmonary v...
Detailed Description
INTRODUCTION AND RATIONALE Cryoballoon ablation has emerged as a safe and effective strategy for the treatment of atrial fibrillation (AF), and based on growing evidence, it recently received an initi...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Cryoballoon PVI+PWI
- Cryoballoon PVI alone
- Symptomatic paroxysmal atrial fibrillation
Exclusion
- None
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT05296824
Start Date
January 1 2014
End Date
December 31 2021
Last Update
November 5 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Mercy General Hospital and Dignity Health Heart and Vascular Institute
Sacramento, California, United States, 95819
2
UC Health Medical Center
Loveland, Colorado, United States, 80538
3
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
4
University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030